Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Galmed Partners with OnKai for Clinical Trial AI models

Galmed Partners with OnKai for Clinical Trial AI models

21st July 2023

AI is being used more and more in the selection process of clinical studies, pairing potential subjects with the most appropriate trials.

Galmed Pharmaceuticals, an Israeli biopharmaceutical business, and OnKai have entered a collaboration, using AI systems to register and run clinical trials in disadvantaged areas.

The partnership will be kicked off with Galmed’s objective to bring their primary sclerosing cholangitis treatment, for chronic liver disease, to market.

Using methods that offer equal eligibility for high-quality treatment and research trials while preserving positions in local clinics, OnKai’s AI planning tool is projected to develop a comprehensive enrolment strategy for every testing stage.

OnKai’s Smart-Grid AI Platform will be employed during clinical testing for a small group of local practices.

During these trials, Galmed will assess the effectiveness of Aramchol for the treatment of inflammatory bowel disease, along with other similar diseases.

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.